1. TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08907 Barcelona, Spain
2. Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), ISCIII, 28029 Madrid, Spain
3. Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, University of Cologne, 50937 Cologne, Germany
4. Clinical Proteomics Unit, IDIBELL, 08908 Barcelona, Spain
5. Proteomic Unit, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, 08916 Badalona, Spain
6. HepatoBiliary Tumors Lab, Centro de Investigación del Cancer and Instituto de Biologia Molecular y Celular del Cancer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain
7. Department of Physiological Sciences, Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain
8. Dermatology Service, IDIBELL, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain
9. Ocular Translational Eye Research Unit, Ophthalmology Department, Spanish Ocular Oncology National Referral Center (CSUR), Hospital Universitari de Bellvitge, 08907 Barcelona, Spain